Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions |
umls-concept:C0001554,
umls-concept:C0003364,
umls-concept:C0008976,
umls-concept:C0012155,
umls-concept:C0013227,
umls-concept:C0020538,
umls-concept:C0027361,
umls-concept:C0035168,
umls-concept:C0392756,
umls-concept:C0497406,
umls-concept:C0547040,
umls-concept:C1257890,
umls-concept:C1273870,
umls-concept:C1280519,
umls-concept:C1514873,
umls-concept:C1948041
|
pubmed:issue |
10 Pt 1
|
pubmed:dateCreated |
1995-2-23
|
pubmed:abstractText |
The Trial of Antihypertensive Interventions and Management (TAIM) was a multicenter randomized drug (double-blind, placebo-controlled)-diet trial. One objective of TAIM was to assess the long-term ability of a low-sodium/high-potassium (Na+ decreases/K+ increases) diet to maintain blood pressure control in persons at 110% to 160% ideal weight with diastolic blood pressure from 90 to 100 mm Hg who were on no drugs or on low-dose monotherapy. Participants, 56% men and 33% black, were randomized to usual diet (n = 296) or to Na+ decreases/K+ increases diet (n = 291) and within each diet group to placebo, 25 mg/day chlorthalidone, or 50 mg/day atenolol. Treatment failure was defined as lack of blood pressure control requiring additional drugs according to specified criteria. At baseline, the mean value for age was 48 years; blood pressure, 143/93 mm Hg; weight, 88 kg; and 24-h urinary sodium and potassium excretion rates, 133 and 57 mmol/day, respectively. At 3 years, the net difference in 24-h urinary sodium/potassium excretion rates between the Na+ decreases/K+ increases and the usual diet groups was -30 and +11 mmol/L/day. The relative risk of treatment failure for Na+ decreases/K+ increases compared to usual diet by proportional hazards regression was 0.95 (P = .71). This study provides no support for the sole use of a low-sodium/high-potassium diet as a practical therapeutic strategy in maintaining blood pressure control in the moderately obese.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Antihypertensive Agents,
http://linkedlifedata.com/resource/pubmed/chemical/Atenolol,
http://linkedlifedata.com/resource/pubmed/chemical/Chlorthalidone,
http://linkedlifedata.com/resource/pubmed/chemical/Potassium,
http://linkedlifedata.com/resource/pubmed/chemical/Potassium, Dietary,
http://linkedlifedata.com/resource/pubmed/chemical/Sodium
|
pubmed:status |
MEDLINE
|
pubmed:month |
Oct
|
pubmed:issn |
0895-7061
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
7
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
926-32
|
pubmed:dateRevised |
2009-2-24
|
pubmed:meshHeading |
pubmed-meshheading:7826557-Adult,
pubmed-meshheading:7826557-Antihypertensive Agents,
pubmed-meshheading:7826557-Atenolol,
pubmed-meshheading:7826557-Chlorthalidone,
pubmed-meshheading:7826557-Combined Modality Therapy,
pubmed-meshheading:7826557-Diet, Sodium-Restricted,
pubmed-meshheading:7826557-Female,
pubmed-meshheading:7826557-Humans,
pubmed-meshheading:7826557-Hypertension,
pubmed-meshheading:7826557-Male,
pubmed-meshheading:7826557-Middle Aged,
pubmed-meshheading:7826557-Obesity,
pubmed-meshheading:7826557-Potassium,
pubmed-meshheading:7826557-Potassium, Dietary,
pubmed-meshheading:7826557-Proportional Hazards Models,
pubmed-meshheading:7826557-Sodium,
pubmed-meshheading:7826557-Treatment Outcome
|
pubmed:year |
1994
|
pubmed:articleTitle |
Lack of effectiveness of a low-sodium/high-potassium diet in reducing antihypertensive medication requirements in overweight persons with mild hypertension. TAIM Research Group. Trial of Antihypertensive Interventions and Management.
|
pubmed:affiliation |
Coordinating Center for Clinical Trials, University of Texas School of Public Health, Houston 77030.
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Research Support, U.S. Gov't, P.H.S.,
Randomized Controlled Trial,
Multicenter Study
|